Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2020-11-03
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Collaborative Care in Posttraumatic Epilepsy
NCT05353452
Incorporating Multidimensional Psychosocial Interventions Improves the Well-being of Individuals With Epilepsy
NCT03484039
Pilot Trial of a Behavioral Treatment for Epilepsy
NCT00212745
Impact of Mindfulness Intervention on Quality of Life in Patients With Drug-resistant Epilepsy.
NCT04126369
Self-management for People With Epilepsy and a History of Negative Health Events
NCT02970396
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The unpredictability of seizures and the unclear behavioral outcomes are major concerns for people with epilepsy and may surface as increased anxiety about independence. This unpredictability is also a true obstacle in capturing and studying seizure-related neurobehavioral alterations themselves. Also, seizures often impact consciousness and thus may go unnoticed. As a result, subjective seizure diaries are unreliable. Continuous smartphone-based monitoring of behavioral output is a fast-emerging topic and proven fruitful in monitoring other neurological disease states. In the field of epilepsy, these tools are yet to be introduced.
Objective:
The investigators hypothesize that quantifying smartphone behavior will help obtain a detailed and objective behavioral map of seizures that can complement existing subjective seizure diaries and thereby improve the way epilepsy treatments are evaluated in daily practice.
Study design:
A multicentre observational prospective cohort study with at least 3 months follow-up.
Study population:
100 subjects with refractory focal epilepsy with a seizure frequency of at least one per month.
Main study parameters/endpoints:
Change in touchscreen interactions (tapping speed, texting speed, apps used, location, sleep-wake cycles) surrounding reported epileptic seizures.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
subjects with refractory focal epilepsy with a seizure frequency
The investigators will include 100 subjects with refractory focal epilepsy with a seizure frequency of at least one per month, and ask them to keep a seizure diary and use the TapCounter app for three months.
Change in touchscreen interactions
The investigators will measure the changes in touchscreen interactions using the TapCounter app by QuantActions
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Change in touchscreen interactions
The investigators will measure the changes in touchscreen interactions using the TapCounter app by QuantActions
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* clinical diagnosis of refractory focal epilepsy meeting ILAE criteria16, 17
* supported by at least one of the following; (1) interictal EEG with epileptiform discharges, (2) epileptogenic lesion on MRI corresponding to the presumed seizure onset zone, or (3) seizure recorded during a video-EEG
* have a seizure frequency of ≥ 1 per month
* only one seizure type, or in case of multiple seizure types only seizures that correspond to one probable onset zone (e.g. focal and focal to bilateral tonic-clonic seizures)
* have daytime seizures (exclusively or both daytime and night-time seizures)
* mentally competent and with no learning disabilities
* able to keep a seizure diary including time and date (as judged by the treating physician)
* have an Android-operating smartphone
* use their phone with at least 5 distinct smartphone apps at a minimum of 5 days a week
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Leiden University
OTHER
Stichting Epilepsie Instellingen Nederland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Roland D Thijs, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Stichting Epilepsie Instellingen Nederland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kempenhaeghe
Heeze, North Brabant, Netherlands
Stichting Epilepsie Instellingen Nederland
Heemstede, North Holland, Netherlands
Maasstad ziekenhuis
Rotterdam, South Holland, Netherlands
University Medical Center Utrecht
Utrecht, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SB&EM
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.